Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose transporter proteins in helminths are integral membrane proteins, typically part of the major facilitator superfamily (MFS), responsible for the uptake of glucose (and sometimes other monosaccharides) from the host environment into the parasite's cells. These transporters are essential for parasite survival, as many helminths lack robust storage of sugars and depend on continuous uptake to fuel glycolysis and maintain intracellular energy balance. Multiple genes can encode different isoforms (e.g., SGTP1-4 in schistosomes, CsGTP4 in C. sinensis), and these may be differentially regulated according to external glucose concentrations. Silencing of specific glucose transporter genes in liver or blood flukes impairs glucose uptake and reduces parasite survival, supporting their potential as drug targets. However, the presence of multiple homologs, alternative pathways for glucose or hexose phosphate acquisition, and the evolutionary similarity to host transporters present ongoing challenges for selective small-molecule targeting.
Competitive inhibition of transporter reduces glucose uptake and starves parasites of essential energy
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose transporter protein in helminth.